CRISPR–mRNA synergy: toward adaptive cancer immunotherapy
CRISPR - mRNA integration represents a promising path toward adaptive, evolution-aware oncology. As delivery and regulatory frameworks advance, combined genome editing and programmable RNA immunotherapy is likely to become a key pillar of future personalized cancer treatment.
Authors
- Özgür Tanriverdi
Institutions
- Muğla University (TR)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1080/14737140.2025.2610271
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00